Lynx1 Capital Management »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Lynx1 Capital Management

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Lynx1 Capital Management from 13F filings

Historical chart of Lynx1 Capital Management investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Lynx1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Lynx1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $177k 9.5k 18.67

More positions owned by Lynx1 Capital Management

Merus N V (MRUS)
Stoke Therapeutics (STOK)
Gh Research Ordinary Shares (GHRS)
C4 Therapeutics Com Stk (CCCC)
Tscan Therapeutics (TCRX)
Cullinan Oncology (CGEM)
Allogene Therapeutics (ALLO)
Longboard Pharmaceuticals In (LBPH)
Passage Bio (PASG)
Cabaletta Bio (CABA)
Ibio Con New (IBIO)
Ibio Con New (IBIO)
Bionomics Ads (BNOX)
Pieris Pharmaceuticals Com New
Kiniksa Pharmaceuticals Intl Ord Shs Cl A

View all positions for Lynx1 Capital Management

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
Fairmount Funds Management
Hillhouse Capital Advisors
Baker Bros. Advisors
Rubric Capital Management
Braidwell
Morgan Stanley
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Dimensional Fund Advisors
Parkman Healthcare Partners
Tang Capital Management
Millennium Management
Driehaus Capital Management

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A